The issue of myopia among children and adolescents continues to receive widespread social attention, with myopia prevention and control evolving into a comprehensive need that includes early screening, risk warning, scientific intervention, long-term follow-up, and health management. The increasing awareness of family health, the advancement of regular school screenings, and the continuous strengthening of medical services are driving sustained demand for myopia prevention and control. The continuous upgrading of the demand structure is also driving the industry to extend from traditional product supply to specialized services, integrated management, and full-cycle intervention.
The myopia management industry for children and adolescents is accelerating its upgrade to a comprehensive myopia management product system. Products and technology paths such as red light therapy and visual training VR continue to attract market attention, driving the industry from single product supply to diversified intervention plans. The requirements for myopia products' access, application, and management are becoming more detailed, and industry channels are shifting towards a more standardized development model that emphasizes coordination among medical institutions, professional optometry services, and primary screening and referral systems.
Children's and adolescent myopia continues to attract broad attention, and myopia management is expanding from simple prevention to a full-cycle approach covering screening, intervention, follow-up, and health management. Growing family awareness, regular school screenings, and stronger medical services are driving sustained demand, while the industry is moving toward more professional, integrated, and comprehensive solutions.
The myopia management industry for children and adolescents is moving toward a more integrated product system. Red light therapy, VR vision training, and other technologies are gaining attention, driving the shift from single products to diversified solutions. Meanwhile, product approval and management are becoming more refined, and industry channels are moving towards a more standardized model built on coordination among medical institutions, professional optometry providers, and primary screening and referral systems.
